Search Results - "Valiña, L."

Refine Results
  1. 1

    PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease by Ge, Preston, Dawson, Valina L, Dawson, Ted M

    Published in Molecular neurodegeneration (13-03-2020)
    “…That certain cell types in the central nervous system are more likely to undergo neurodegeneration in Parkinson's disease is a widely appreciated but poorly…”
    Get full text
    Journal Article
  2. 2

    Microglia and astrocyte dysfunction in parkinson's disease by Kam, Tae-In, Hinkle, Jared T., Dawson, Ted M., Dawson, Valina L.

    Published in Neurobiology of disease (01-10-2020)
    “…While glia are essential for regulating the homeostasis in the normal brain, their dysfunction contributes to neurodegeneration in many brain diseases,…”
    Get full text
    Journal Article
  3. 3

    The cell biology of Parkinson's disease by Panicker, Nikhil, Ge, Preston, Dawson, Valina L, Dawson, Ted M

    Published in The Journal of cell biology (05-04-2021)
    “…Parkinson's disease (PD) is a progressive neurodegenerative disorder resulting from the death of dopamine neurons in the substantia nigra pars compacta. Our…”
    Get full text
    Journal Article
  4. 4

    Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities by Fatokun, Amos A, Dawson, Valina L, Dawson, Ted M

    Published in British journal of pharmacology (01-04-2014)
    “…Cells die by a variety of mechanisms. Terminally differentiated cells such as neurones die in a variety of disorders, in part, via parthanatos, a process…”
    Get full text
    Journal Article
  5. 5

    PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease by Shin, Joo-Ho, Ko, Han Seok, Kang, Hochul, Lee, Yunjong, Lee, Yun-Il, Pletinkova, Olga, Troconso, Juan C., Dawson, Valina L., Dawson, Ted M.

    Published in Cell (04-03-2011)
    “…A hallmark of Parkinson's disease (PD) is the preferential loss of substantia nigra dopamine neurons. Here, we identify a new parkin interacting substrate,…”
    Get full text
    Journal Article
  6. 6

    Genetic Animal Models of Parkinson's Disease by Dawson, Ted M., Ko, Han Seok, Dawson, Valina L.

    Published in Neuron (Cambridge, Mass.) (10-06-2010)
    “…Parkinson's disease (PD) is a progressive neurodegenerative disorder that is characterized by the degeneration of dopamine (DA) and non-DA neurons, the almost…”
    Get full text
    Journal Article
  7. 7

    The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration by Hinkle, Jared T., Dawson, Valina L., Dawson, Ted M.

    Published in Movement disorders (01-07-2019)
    “…We recently demonstrated that NLY01, a novel glucagon‐like peptide‐1 receptor agonist, exerts neuroprotective effects in two mouse models of PD in a…”
    Get full text
    Journal Article
  8. 8

    Mitochondrial Mechanisms of Neuronal Cell Death: Potential Therapeutics by Dawson, Ted M, Dawson, Valina L

    “…Mitochondria lie at the crossroads of neuronal survival and cell death. They play important roles in cellular bioenergetics, control intracellular Ca 2+…”
    Get full text
    Journal Article
  9. 9

    The role of parkin in familial and sporadic Parkinson's disease by Dawson, Ted M., Dawson, Valina L.

    Published in Movement disorders (2010)
    “…Mutations in parkin are the second most common known cause of Parkinson's disease (PD). Parkin is an ubiquitin E3 ligase that monoubiquitinates and…”
    Get full text
    Journal Article Conference Proceeding
  10. 10
  11. 11

    LRRK2 pathobiology in Parkinson's disease by Martin, Ian, Kim, Jungwoo Wren, Dawson, Valina L., Dawson, Ted M.

    Published in Journal of neurochemistry (01-12-2014)
    “…Mutations in the catalytic Roc‐COR and kinase domains of leucine‐rich repeat kinase 2 (LRRK2) are a common cause of familial Parkinson's disease (PD). LRRK2…”
    Get full text
    Journal Article
  12. 12

    Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes by Scott, Laura, Dawson, Valina L., Dawson, Ted M.

    Published in Experimental neurology (01-12-2017)
    “…Parkinson's disease (PD) is a neurodegenerative movement disorder characterized by the progressive loss of dopaminergic (DA) neurons. Most PD cases are…”
    Get full text
    Journal Article
  13. 13

    MicroRNA-223 is neuroprotective by targeting glutamate receptors by Harraz, Maged M, Eacker, Stephen M, Wang, Xueqing, Dawson, Ted M, Dawson, Valina L

    “…Stroke is a major cause of mortality and morbidity worldwide. Extracellular glutamate accumulation leading to overstimulation of the ionotropic glutamate…”
    Get full text
    Journal Article
  14. 14

    The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease by Karuppagounder, Senthilkumar S., Brahmachari, Saurav, Lee, Yunjong, Dawson, Valina L., Dawson, Ted M., Ko, Han Seok

    Published in Scientific reports (02-05-2014)
    “…c-Abl is activated in the brain of Parkinson's disease (PD) patients and in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice where it…”
    Get full text
    Journal Article
  15. 15

    Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease by Martin, Ian, Kim, Jungwoo Wren, Lee, Byoung Dae, Kang, Ho Chul, Xu, Jin-Chong, Jia, Hao, Stankowski, Jeannette, Kim, Min-Sik, Zhong, Jun, Kumar, Manoj, Andrabi, Shaida A, Xiong, Yulan, Dickson, Dennis W, Wszolek, Zbigniew K, Pandey, Akhilesh, Dawson, Ted M, Dawson, Valina L

    Published in Cell (10-04-2014)
    “…Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and sporadic Parkinson's disease (PD). Elevated LRRK2 kinase activity and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Parkin and PINK1: much more than mitophagy by Scarffe, Leslie A, Stevens, Daniel A, Dawson, Valina L, Dawson, Ted M

    Published in Trends in neurosciences (Regular ed.) (01-06-2014)
    “…Highlights • Parkinson's disease is a mitochondrial disease of aging. • PINK1 and parkin are key players in multiple domains of mitochondrial health. • PINK1…”
    Get full text
    Journal Article
  18. 18

    Poly(ADP-ribose) signals to mitochondrial AIF: A key event in parthanatos by Wang, Yingfei, Dawson, Valina L., Dawson, Ted M.

    Published in Experimental neurology (01-08-2009)
    “…Poly(ADP-ribose) polymerase-1 (PARP-1) plays a pivotal role in multiple neurologic diseases by mediating caspase-independent cell death, which has recently…”
    Get full text
    Journal Article
  19. 19

    Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke by Yang, Liu, Guttman, Lauren, Dawson, Valina L., Dawson, Ted M.

    Published in Biochemical pharmacology (01-10-2024)
    “…[Display omitted] Parthanatos is a cell death signaling pathway that has emerged as a compelling target for pharmaceutical intervention. It plays a pivotal…”
    Get full text
    Journal Article
  20. 20

    Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain by Kageyama, Yusuke, Hoshijima, Masahiko, Seo, Kinya, Bedja, Djahida, Sysa-Shah, Polina, Andrabi, Shaida A, Chen, Weiran, Höke, Ahmet, Dawson, Valina L, Dawson, Ted M, Gabrielson, Kathleen, Kass, David A, Iijima, Miho, Sesaki, Hiromi

    Published in The EMBO journal (01-12-2014)
    “…Mitochondrial dynamics and mitophagy have been linked to cardiovascular and neurodegenerative diseases. Here, we demonstrate that the mitochondrial division…”
    Get full text
    Journal Article